The Impact of Daily Carbohydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-loop System
NCT05866900 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2023-05-19
Summary
Lifestyle factors, including diet, play an important role in the achievement of glycemic targets in patients with diabetes, even with the use of automated insulin delivery (AID) systems. Advanced hybrid closed-loop systems (AHCL), by implementing innovative and powerful control algorithms, have been shown to improve the post-meal glycemic control in their users through the delivery of automatic correction boluses. However, data about the influence of the daily amount of carbohydrate intake on glycemic outcomes in youth with type 1 diabetes using AHCL are missing. Therefore, this study will evaluate the association between daily carbohydrate intakes and meal patterns on glycemic control of young people living with type 1 diabetes using an AHCL system (Medtronic MiniMed 780G; Medtronic, Northridge, California) under real-life conditions.
Conditions
- Diabetes Mellitus, Type 1
Interventions
- DEVICE
-
MiniMed 780G with SmartGuard activated
The MiniMed 780G system consists of a MiniMed 780G Insulin Pump connected to Guardian 4 Sensor or Guardian 3 Sensor, using an automated insulin delivery algorithm called SmartGuard.
Sponsors & Collaborators
-
University of Messina
collaborator OTHER -
University of Ljubljana, Faculty of Medicine
lead OTHER
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-15
- Primary Completion
- 2023-08-31
- Completion
- 2023-10-31
- FDA Device
- Yes
More Related Trials
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
NCT02846831 ·Status: COMPLETED ·Phase: PHASE2
-
Automated Closed-loop in Children and Adolescents With Type 1 Diabetes
NCT02129868 ·Status: COMPLETED ·Phase: NA
-
Simple Meal Management Using Automated Insulin Delivery System
NCT06130215 ·Status: RECRUITING ·Phase: NA
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
NCT02846857 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
NCT06283797 ·Status: RECRUITING ·Phase: NA
-
Achieving Rapid, Safe and Sustained Glucose Control in Adolescents With Suboptimally Controlled Type 1 Diabetes Using Advanced Hybrid Closed Loop Systems
NCT06305377 ·Status: NOT_YET_RECRUITING
-
AHCL System Initiation in T1D Patients naïve to Technology
NCT04616391 ·Status: UNKNOWN ·Phase: NA
-
Simple Initiation of Advanced Hybrid Closed Loop System
NCT05069727 ·Status: COMPLETED ·Phase: NA
-
Diabeloop for Teens
NCT04725591 ·Status: COMPLETED ·Phase: NA
-
Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children
NCT02179281 ·Status: COMPLETED ·Phase: NA
-
Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes
NCT04807374 ·Status: COMPLETED ·Phase: NA
-
Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?
NCT03300934 ·Status: COMPLETED ·Phase: NA
-
Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
NCT04053712 ·Status: COMPLETED ·Phase: PHASE4
-
Fuzzy Logic Automated Insulin Regulation
NCT03040414 ·Status: COMPLETED ·Phase: NA
-
Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years
NCT04949022 ·Status: UNKNOWN ·Phase: NA
-
Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes
NCT04949867 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Automated Insulin Delivery on Early-stage Diabetic Complications
NCT05477030 ·Status: UNKNOWN ·Phase: NA
-
Glycemic Control and the Brain in Children With Type 1 Diabetes
NCT03428932 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
NCT02488616 ·Status: WITHDRAWN ·Phase: PHASE2
-
Hybrid Closed Loop Insulin Delivery System in Hypoglycemia
NCT03215914 ·Status: COMPLETED ·Phase: NA
-
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.
NCT07241702 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Minimed 670G in T1D Patients on Multiple Daily Injection
NCT03755479 ·Status: COMPLETED
-
Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes
NCT01930097 ·Status: COMPLETED ·Phase: PHASE2
-
Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions
NCT02727231 ·Status: COMPLETED ·Phase: NA
-
Automated Overnight Closed-loop Glucose Control in Young People With Type 1 Diabetes
NCT00989898 ·Status: COMPLETED ·Phase: NA